Demystifying HealthEquity: Insights From 11 Analyst Reviews
Portfolio Pulse from Benzinga Insights
HealthEquity (NASDAQ:HQY) has been analyzed by 11 analysts over the past three months, showing a range of perspectives from bullish to bearish. The average 12-month price target is $103.82, with a high of $110.00 and a low of $92.00. Recent analyst actions have predominantly been positive, with several raising their price targets.
June 20, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HealthEquity has received predominantly positive analyst reviews, with several analysts raising their price targets. The average 12-month price target is now $103.82, up from $98.10.
The majority of analysts have raised their price targets for HealthEquity, indicating increased confidence in the company's future performance. The average price target has increased by 5.83%, suggesting a positive outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100